People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| HedgePath Pharmaceuticals, Inc. | — | Pharmaceuticals | Pre-Seed | $600K | $28.4M | 2016 |
R. Dana Ono, MD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside R. Dana Ono, MD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Samuel P. Sears, Jr. | 1 | 1 |
| Frank E. O'Donnell, Jr., MD | 1 | 1 |
| Nicholas J. Virca | 1 | 1 |
| W. Mark Watson, CPA | 1 | 1 |
| Garrison J. Hasara, CPA | 1 | 1 |
| Stefan J. Cross | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.